518
Participants
Start Date
February 13, 2023
Primary Completion Date
February 16, 2024
Study Completion Date
February 16, 2024
V116
Pneumococcal 21-valent conjugate vaccine with 4 μg of each of the following pneumococcal polysaccharides (PnPs) antigen: 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20, 22F, 23A, 23B, 24F, 31, 33F, and 35B in each 0.5 mL sterile solution
Placebo
Saline in each 0.5 mL sterile solution
PCV15
Pneumococcal 15-valent conjugate vaccine with 2 μg of each of the following PnPs antigen: 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F; and 4 μg of PnPs antigen 6B in each 0.5 mL sterile suspension
PPSV23
Pneumococcal 23-valent polyvalent vaccine with 25 μg of each of the following PnPs antigen: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F in each 0.5 mL sterile solution
Holdsworth House Medical Practice ( Site 0402), Darlinghurst
Pacific Clinical Research Network - Rotorua ( Site 0500), Rotorua
P3 Research - Tauranga ( Site 0507), Tauranga
Royal Brisbane and Women's Hospital ( Site 0400), Brisbane
P3 Research - Lower Hutt ( Site 0508), Lower Hutt
P3 Research - Wellington ( Site 0503), Wellington
CGM Research Trust ( Site 0505), Christchurch
Pacific Clinical Research Network - Forte ( Site 0501), Christchurch
Mid Hudson Medical Research ( Site 0008), New Windsor
Hallym University Sacred Heart Hospital ( Site 0303), Anyang-si
EmVenio Research ( Site 0018), Fort Worth
Indago Research & Health Center, Inc ( Site 0002), Hialeah
Triple O Research Institute, P.A ( Site 0011), West Palm Beach
Holston Medical Group ( Site 0010), Kingsport
SKY Integrative Medical Center/SKYCRNG ( Site 0012), Ridgeland
Aventiv Research ( Site 0022), Mesa
Wenatchee Valley Hospital ( Site 0019), Wenatchee
Centro de Investigación del Maule-Centro de Investigación 2 ( Site 1010), Talca
Hospital Dr. Hernán Henríquez Aravena ( Site 1001), Temuco
Universidad San Sebastian - Providencia ( Site 1003), Providencia
Centro de Investigaciones Medicas Respiratorias (CIMER) ( Site 1008), Santiago
Centro de Investigacion Clinicadela Universidad Catolica ( Site 1004), Santiago
Universidad de Chile - Hospital Clínico Universidad de Chile-Cardiology ( Site 1006), Santiago
CESFAM Esmeralda ( Site 1009), Santiago
G A Research Associates ( Site 0100), Moncton
Hamilton Medical Research Group ( Site 0107), Hamilton
Milestone Research Inc. ( Site 0106), London
Manna Research Mirabel ( Site 0105), Mirabel
Clinique de médecine Urbaine du Quartier Latin ( Site 0111), Montreal
Diex Recherche Trois-Rivieres ( Site 0110), Trois-Rivières
Diex Recherche Victoriavile Inc. ( Site 0102), Victoriaville
Medical corporation Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic ( Site 0200), Kurume
Shimonoseki Medical Center ( Site 0201), Shimonoseki
IN VIVO ( Site 0601), Bydgoszcz
Centrum Medyczne Pratia Bydgoszcz-Centrum Medyczne Pratia Bydgoszcz ( Site 0607), Bydgoszcz
MICS Centrum Medyczne Torun ( Site 0606), Torun
Centrum Medyczne Medyk ( Site 0602), Rzeszów
Centrum Medyczne Pratia Katowice ( Site 0604), Katowice
Clinical Medical Research ( Site 0605), Katowice
Clinmedica Research Sp. z. o. o. ( Site 0603), Skierniewice
Korea University Anam Hospital ( Site 0305), Seoul
Seoul National University Hospital ( Site 0300), Seoul
Konkuk University Medical Center ( Site 0302), Seoul
Hallym University Kangdong Sacred Heart Hospital ( Site 0301), Seoul
Merck Sharp & Dohme LLC
INDUSTRY